Who is sponsoring NCT01589328?

NCT01589328 is sponsored by National Cancer Center, Korea.

What drugs are being tested in NCT01589328?

Interventions in NCT01589328: Early Palliative care integrated with usual oncologic care.

What condition does NCT01589328 study?

NCT01589328 studies Pancreatic Cancer, Biliary Tract Cancer, Cancer Pain, Depression.

Is NCT01589328 still recruiting?

NCT01589328 is currently completed. Last updated 3 January 2018.

Last reviewed 2018-01-03 · How we verify

NCT01589328: EPADE-PB

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Early Management on PAin and DEpression in Patients With PancreatoBiliary Cancer, EPADE-PB

Completed NA Last updated 3 January 2018

What this trial tests

NA trial testing Early Palliative care integrated with usual oncologic care in Pancreatic Cancer in 288 participants. Completed in 30 June 2017.

Timeline

15 March 2012

Primary endpoint
30 June 2017

30 June 2017

Quick facts

Lead sponsor	National Cancer Center, Korea
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	288
Start date	15 March 2012
Primary completion	30 June 2017
Estimated completion	30 June 2017
Sites	1 location across South Korea

Drugs / interventions tested

Early Palliative care integrated with usual oncologic care

Conditions studied

Pancreatic Cancer — all drugs for Pancreatic Cancer →
Biliary Tract Cancer — all drugs for Biliary Tract Cancer →
Cancer Pain — all drugs for Cancer Pain →
Depression — all drugs for Depression →

Sponsor

National Cancer Center, Korea

Who can join

18 and older, any sex, with Pancreatic Cancer or Biliary Tract Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Effect of Early management on PAin and DEpression in patients with PancreatoBiliary Cancer, EPADE-PB Purpose To determine whether early palliative care integrated with usual oncologic care with automated symptom monitoring can improve depression and pain in patients with cancer

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Early palliative care for adults with advanced cancer.
Haun MW, Estel S, Rücker G, Friederich HC, et al · · 2017 · cited 369× · PMID 28603881 · DOI 10.1002/14651858.cd011129.pub2
Intrahepatic cholangiocarcinoma: current perspectives.
Buettner S, van Vugt JL, IJzermans JN, Groot Koerkamp B. · · 2017 · cited 100× · PMID 28260927 · DOI 10.2147/ott.s93629

Verify or expand the search:

Other recruiting trials for Pancreatic Cancer

Currently open trials in the same condition.

NCT07126158 — Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma · Phase 2 · recruiting
NCT07353645 — KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer · Phase 1, PHASE2 · recruiting
NCT07439757 — AI-Powered Precision Decision-Making for Pancreatic Diseases · recruiting
NCT07409272 — A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherap · Phase 3 · recruiting
NCT07236177 — B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosi · EARLY_PHASE1 · recruiting

Other National Cancer Center, Korea trials

Trials by the same sponsor.

NCT07399561 — Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy · NA · not yet recruiting
NCT07121478 — Patients With High-grade Pancreatic Neuroendocrine Tumors · Phase 2 · enrolling by invitation
NCT07171528 — Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer · Phase 2 · recruiting
NCT07125924 — Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer · NA · not yet recruiting
NCT07041515 — Knowledge-enhanced Digital Intervention to Prevent Low Anterior Resection Syndrome · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01589328 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Cancer Center, Korea
Last refreshed: 3 January 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01589328.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing